Loading organizations...
Molecular Quantum Solutions (MQS) develops a computational chemistry platform, integrating quantum chemistry with data-driven algorithms. This enterprise software predicts biochemical properties, accelerating R&D in chemistry, materials science, and pharmaceuticals by reducing experimental needs. Leveraging high-performance cloud infrastructure, it provides rapid, precise insights into molecular behavior.
MQS was founded in December 2019 by Mark Nicholas Jones (CEO), Lukasz Ruszczynski (CTO), and Kurt Stokbro (Co-founder and Chairman). The founders recognized quantum chemistry and data science's potential to transform material and drug discovery. Their combined expertise demonstrated that advanced computational tools could substantially streamline extensive experimental phases in traditional R&D.
MQS primarily serves pharmaceutical, biotech, and chemical industries, optimizing clients' R&D, product development, and process design through sophisticated simulations. The company envisions democratizing access to these advanced computational tools, fostering faster discovery and development of novel materials and chemicals, enhancing innovation across these vital sectors.
Molecular Quantum Solutions has raised $1.8M across 2 funding rounds.
Molecular Quantum Solutions has raised $1.8M in total across 2 funding rounds.
Molecular Quantum Solutions has raised $1.8M across 2 funding rounds. Most recently, it raised $970K Seed in June 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jun 1, 2023 | $970K Seed | — | Scale Capital | Announced |
| May 1, 2023 | $800K Seed | — | Scale Capital | Announced |
Molecular Quantum Solutions (MQS) is a Danish technology startup founded in 2019 that builds an enterprise software platform called Cebule for accelerating R&D in biopharmaceuticals, biotech, and chemicals.[1][2][4][5] It serves pharma, biotech, chemical industries, and research institutions by predicting molecular properties like solubility and density using quantum chemistry, molecular dynamics, machine learning, graph neural networks, and high-performance computing on supercomputers and quantum processors (QPUs).[1][2][3][4][5] This solves key pain points: lack of experimental data, inaccurate physical models, and time/material-intensive lab tests, enabling virtual screening for drugs, batteries, green solvents, and biodegradable plastics while cutting R&D costs in a $407B industry.[2][3][4] At pre-seed stage with $660K raised (last in 2023), it operates from Søborg, Denmark, with 1-10 employees and tools like APIs, JupyterLab, Kubeflow, and a dashboard for 200M+ molecules.[1][4][5]
MQS was founded in 2019 in Søborg, Denmark, by an interdisciplinary team at the intersection of quantum chemistry, quantum computing, chemical engineering, computer science, and lab automation.[1][4][5] Key figures include CEO/CTO and co-founder (Postdoc background, Mark Jones), co-founder/investor/chairman, lead for quantum technology development, and a quantum computing methods developer on industrial PhD.[4][5] The idea emerged from addressing R&D bottlenecks where scientists lack data or reliable models for simulating processes and products, leading to the development of Cebule—a pipeline combining quantum chemistry, molecular dynamics, and ML to minimize experiments.[2][4] Early traction includes pre-seed funding of $660K, AWS Marketplace presence, and integration into quantum tech expert collections, with a small team leveraging flexible work and skill development perks.[1][3][4]
MQS rides the quantum computing and hybrid HPC-ML wave in computational chemistry, targeting a surge in drug/material discovery amid rising R&D costs and sustainability demands.[1][2][3] Timing aligns with quantum tech maturation—events like IQT Nordics 2025 and expert collections highlight its fit in "Quantum Tech" and "Future of the Factory," where quantum advantages speed simulations infeasible on classical systems.[1][5] Market forces favor it: biopharma/chemical sectors need faster virtual screening to cut $407B R&D expenses, boosted by cloud access (AWS) and green innovation pushes for batteries/solvents.[3][4] It influences the ecosystem by democratizing quantum tools via APIs/containers, enabling smaller firms/institutions to compete and accelerating transitions from lab to production.[2][5]
MQS is poised to scale Cebule amid quantum hardware advances and AI integration, potentially expanding partnerships for QPU access and robotic lab validation to hit product-market fit post-pre-seed.[1][5] Trends like exponential quantum progress (echoing Niels Bohr's quote) and MLOps in chem eng will propel it, with focus on sustainable materials/drugs driving growth in a maturing quantum software market.[4][5] Its influence may evolve from niche predictor to ecosystem platform, powering collaborative R&D and reducing global experiment reliance—watch for seed funding and enterprise wins to confirm momentum in this high-potential space.[1][2]
Molecular Quantum Solutions has raised $1.8M in total across 2 funding rounds.
Molecular Quantum Solutions's investors include Scale Capital.
